IBDEI0KV ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10227,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,10228,0)
 ;;=382.9^^67^673^49
 ;;^UTILITY(U,$J,358.3,10228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10228,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,10228,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,10228,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,10229,0)
 ;;=614.9^^67^673^50
 ;;^UTILITY(U,$J,358.3,10229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10229,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,10229,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,10229,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,10230,0)
 ;;=486.^^67^673^52
 ;;^UTILITY(U,$J,358.3,10230,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10230,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,10230,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,10230,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,10231,0)
 ;;=136.3^^67^673^51
 ;;^UTILITY(U,$J,358.3,10231,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10231,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,10231,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,10231,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,10232,0)
 ;;=601.9^^67^673^56
 ;;^UTILITY(U,$J,358.3,10232,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10232,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,10232,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,10232,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,10233,0)
 ;;=590.80^^67^673^57
 ;;^UTILITY(U,$J,358.3,10233,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10233,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,10233,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,10233,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,10234,0)
 ;;=711.00^^67^673^58
 ;;^UTILITY(U,$J,358.3,10234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10234,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,10234,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,10234,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,10235,0)
 ;;=461.9^^67^673^60
 ;;^UTILITY(U,$J,358.3,10235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10235,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,10235,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,10235,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,10236,0)
 ;;=473.9^^67^673^59
 ;;^UTILITY(U,$J,358.3,10236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10236,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,10236,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,10236,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,10237,0)
 ;;=091.0^^67^673^65
 ;;^UTILITY(U,$J,358.3,10237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10237,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,10237,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,10237,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,10238,0)
 ;;=097.0^^67^673^63
 ;;^UTILITY(U,$J,358.3,10238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10238,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,10238,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,10238,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,10239,0)
 ;;=094.9^^67^673^64
 ;;^UTILITY(U,$J,358.3,10239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10239,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,10239,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,10239,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,10240,0)
 ;;=097.9^^67^673^62
 ;;^UTILITY(U,$J,358.3,10240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10240,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,10240,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,10240,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,10241,0)
 ;;=463.^^67^673^66
 ;;^UTILITY(U,$J,358.3,10241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10241,1,4,0)
 ;;=4^463.
 ;;^UTILITY(U,$J,358.3,10241,1,5,0)
 ;;=5^Tonsillitis
